FDA Proposes New Front-of-Package Nutrition Label to Help Consumers Make Healthier Choices
FDA proposes a new front-of-package nutrition label to help consumers make healthier food choices, focusing on key nutrients like saturated fat, sodium, and added sugars, promoting better public health.
APMC Conducts Innovative Study on Medicinal Cannabis for Osteoporosis and Chronic Pain in Women
The Pan American Association of Cannabinoid Medicine (APMC) is leading an innovative study on the use of medicinal cannabis in the treatment of osteoporosis and chronic pain in women. The research investigates bone biomarkers and genetic polymorphisms to personalize therapies and expand access to treatment within the SUS.
Resolution No. 954: Changes to Drug Registration Take Effect
What changes with Anvisa Resolution No. 954? The new regulation, set to take effect on January 21, 2025, introduces adjustments to drug registration, post-registration, and renewal processes, enhancing transparency and sanitary control.
FDA issues preliminary guidance for medical devices with Artificial Intelligence
First Guidance to Provide Comprehensive Recommendations for Artificial Intelligence in Medical Devices for Developers
FDA Proposes Draft Guidance to Ensure AI Credibility in Drug and Biologic Submissions
FDA releases comprehensive guidance draft with recommendations on the use of artificial intelligence to support regulatory decisions regarding the safety, efficacy, and quality of drugs and biologics.
Anvisa Updates Procedures for Borderline Products
The National Health Surveillance Agency (Anvisa) recently updated its guidelines on the procedures for classifying border products.
EMA launches a public consultation on the use of real-world data in the regulation of medicines.
The EMA opens a public consultation on the use of data in the regulation of medicines under the Data Quality Framework for the Regulation of Medicines.